Mona Alqulali, MD
Obstetrics & Gynecology · Clinton, IANPI 1497722979
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Olympus Corporation Of The Americas at 51.6% of the total. Reporting peaked in 2019 at $2,256 and has fallen 89.9% since, to $228 in 2025.
Across 93 payments — averaging $38.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus Corporation Of The Americas$2K
- AbbVie$325
- Novo Nordisk$238
- AstraZeneca$199
- Astellas Pharma US Inc$150
- Lilly USA, LLC$139
- plus $668 from 19 others
What the payments were for
- Travel & lodging$1,47041%
- Food & beverage$1,97156%
- Education$1063%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus Corporation Of The Americas | 11 | $1,830 |
| AbbVie | 13 | $325 |
| Novo Nordisk | 9 | $238 |
| AstraZeneca | 14 | $199 |
| Astellas Pharma US Inc | 4 | $150 |
| Lilly USA, LLC | 11 | $139 |
| Hologic Sales And Service, LLC | 1 | $92 |
| Bayer | 4 | $89 |
| Idorsia Pharmaceuticals US Inc | 4 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| Alydia Health | 2 | $57 |
| Medtronic | 2 | $52 |
| Upsher-smith Laboratories LLC | 2 | $34 |
| Davol Inc. | 1 | $33 |
| Lupin Inc. | 2 | $30 |
| Merz North America, Inc. | 1 | $19 |
| Abbott | 1 | $18 |
| Myovant Sciences Inc. | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| Amgen | 1 | $16 |
| Shire North American Group Inc | 1 | $15 |
| Pfizer | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Channel Medsystems, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ThunderBeat$1,563
- Saxenda$120
- NATRELLE SALINE-FILLED BREAST IMPLANTS$103
How this compares
$3,547 in reported general payments places this provider in the 85th percentile of 274 obstetrics & gynecology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 67 | $81,937 |
| TrulicityDulaglutide | 66 | $79,956 |
| MounjaroTirzepatide | 22 | $30,282 |
| FarxigaDapagliflozin Propanediol | 36 | $26,594 |
| OzempicSemaglutide | 14 | $18,668 |
| RybelsusSemaglutide | 13 | $12,750 |
| ProgesteroneProgesterone, Micronized | 93 | $4,942 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $2,653 |
| Estradiol | 122 | $2,117 |
| Testosterone | 11 | $1,616 |
| Bromocriptine Mesylate | 19 | $1,586 |
| Metformin Hcl | 269 | $1,479 |
| LevemirInsulin Detemir | 11 | $1,201 |
| Solifenacin Succinate | 11 | $913 |
| Topiramate | 17 | $891 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $139 | $110,23888 claims |
| Boehringer IngelheimJardiance | $14 | $81,93767 claims |
| Novo NordiskOzempic, Rybelsus, Levemir | $238 | $32,61938 claims |
| AstraZenecaFarxiga, Symbicort | $199 | $29,24747 claims |
| Upsher-smith Laboratories LLCTopiramate | $34 | $89117 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 274 obstetrics & gynecology providers in Iowa.
Other obstetrics & gynecology in Clinton
- Jorge SotolongoCouncil Bluffs$171K
- Laura NealDubuque$157K
- Amy BingamanDes Moines$44K
- Alvadore OsbornWest Des Moines$34K
- Jason RexrothCedar Rapids$16K
- Maxwell MageeWest Des Moines$16K
- Lori PlattCouncil Bluffs$14K
- Heather MarthersWaterloo$14K
- Jerry RozeboomCedar Rapids$12K
- Emily Boevers SolversonIowa City$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.